Clinical Trial Update: FSRT in Breast Cancer Patients With Brain Metastases [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating frameless stereotactic radiotherapy (FSRT) in breast cancer patients with brain metastases.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Breast Cancer

Snippet

Sponsor: Fudan University | Conditions: Breast Cancer, Brain Metastases | Phase 2 | Status: UNKNOWN